End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.71 CNY | -2.22% | +3.41% | -11.73% |
Apr. 29 | Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 29 | Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 1.82B 252M | Sales 2023 | 1.37B 190M | Capitalization | 5.58B 772M |
---|---|---|---|---|---|
Net income 2022 | 499M 69.07M | Net income 2023 | 280M 38.76M | EV / Sales 2022 | 3.17 x |
Net cash position 2022 | 566M 78.4M | Net cash position 2023 | 270M 37.31M | EV / Sales 2023 | 3.88 x |
P/E ratio 2022 |
12.8
x | P/E ratio 2023 |
20
x | Employees | 2,508 |
Yield 2022 |
2.72% | Yield 2023 |
-
| Free-Float | 52.62% |
1 day | -2.22% | ||
1 week | +3.41% | ||
Current month | +3.41% | ||
1 month | +6.70% | ||
3 months | +11.48% | ||
6 months | -15.64% | ||
Current year | -11.73% |
Managers | Title | Age | Since |
---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 02-03-07 |
Wen Ni
DFI | Director of Finance/CFO | 41 | 12-12-31 |
Gang Zhu
BRD | Director/Board Member | 38 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 02-03-07 |
Bin Yan
BRD | Director/Board Member | 42 | 09-12-31 |
En Kui Su
BRD | Director/Board Member | 62 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - | |
0.00% | 0 M€ | +3.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.71 | -2.22% | 4,820,808 |
24-05-09 | 9.93 | +0.81% | 4,551,204 |
24-05-08 | 9.85 | +0.10% | 6,466,496 |
24-05-07 | 9.84 | 0.00% | 5,032,588 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-11.73% | 682M | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+5.68% | 5.66B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B |
- Stock Market
- Equities
- 603387 Stock